Last reviewed · How we verify
NCT07299721: Brain Ultrafas
Brain Ultrafast Ultrasound Imaging
trial testing Ultrafast ultrasound (UFUS) in CHD - Congenital Heart Disease in 300 participants. Not yet recruiting.
1 January 2026
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 January 2026 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 January 2029 |
| Sites | 1 location across France |
Drugs / interventions tested
- Ultrafast ultrasound (UFUS)
Conditions studied
- CHD - Congenital Heart Disease — all drugs for CHD - Congenital Heart Disease →
Sponsor
University Hospital, Bordeaux
Who can join
Adults 0 to 2, any sex, with CHD - Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Congenital heart defects affect 1 in 100 births in France, with rising prevalence due to better care. Despite improved survival, 40% of children post-surgery face neurological impairments, and some of them show brain lesions. Causes include heart defects, genetic syndromes, and surgeries. Some heart defects and support systems increase cerebral risks. Monitoring cerebral perfusion is difficult to assess but emerging ultrafast ultrasound offers real-time, non-invasive blood flow insights.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07299721
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for CHD - Congenital Heart Disease
Currently open trials in the same condition.
- NCT07255144 — Ultrafast Ultrasound Imaging in Pediatric Cardiology · recruiting
- NCT04216927 — NO During CPB in Neonates to Reduce Risk of AKI · Phase 3 · recruiting
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07299721 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 23 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07299721.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing